Blog

Aurora Cannabis (ACB) is rapidly proving to be the top cannabis production company in the world, as none of its competitors are even close in production capacity; it’s one of the top revenue generators in the sector; and within this quarter or the next, is going to produce positive EBITDA.

support@smarteranalyst.com (Ben Mahaney)SmarterAnalystJune 27, 2019 0:06 4:54   How cannabisMD aims to educate consumers about the medical side to cannabis culture

Aurora Cannabis (ACB) is rapidly proving to be the top cannabis production company in the world, as none of its competitors are even close in production capacity; it’s one of the top revenue generators in the sector; and within this quarter or the next, is going to produce positive EBITDA.

With its foot on the accelerator in these areas and others, it’s going to become increasingly a

Aurora Cannabis (ACB) is rapidly proving to be the top cannabis production company in the world, as none of its competitors are even close in production capacity; it’s one of the top revenue generators in the sector; and within this quarter or the next, is going to produce positive EBITDA.

With its foot on the accelerator in these areas and others, it’s going to become increasingly apparent that it’s the bellwether or the cannabis sector, and it won’t be long before the market starts rewarding it for that.

Many in the market are looking at the wrong things

For now Canopy Growth has received a higher valuation than Aurora, primarily because it is operating in a manner the market understands. For example, accepting and receiving a large cash infusion from Constellation Brands, that is always waves in front of the market in its earnings report and press releases.

Since Aurora hasn’t been willing to give up a significant portion of the company in exchange for an investment by a huge suitor, the market has punished it for it when compared against Canopy Growth.

Another factor has been the hoopla surrounding Canopy Growth preparing to enter the U.S. market via Acreage Holdings once recreational pot is legalized at the federal level, which at best, won’t happen for many years.

In both of those cases many analysts and pundits compared Canopy against Aurora, concluding Canopy had made the best moves. After its surprising C$98-million loss in the first quarter, the market seems to be reconsidering the performance of Canopy Growth, even with the $4 billion or so on its balance sheet.

For Aurora, I consider it a wise move to not sell off a huge piece of itself in exchange for capital and board seats from a huge company, and also a good move to find a more opportune time and way to enter the U.S. market.

I don’t consider these a negative for Aurora, but the opposite: disciplined decisions and patience that as usual with the company, pays off in big dividends once it’s understood the strategy the company is employing.

Production capacity, revenue and positive EBITDA

No company comes close to Aurora Cannabis in production capacity, as it should be able to produce about 625,000 kilograms annually by early 2020, and of course its revenue will climb in conjunction with the increase.

What’s most impressive about this when measured against any of the top producers is Aurora will be easily the first company to become profitable in the sector. This is one of the major reasons billionaire Nelson Pelz had advised the company that it didn’t have any reason to seek out a major partner for the purpose of raising capital.

That doesn’t mean the company isn’t going to enter into some partnerships with large companies, only that they’re going to be structured differently than giving up large stakes in the Aurora in exchange for cash. I expect them to be more on the distribution side of the business with shared profits.

Profitability is expected in the current quarter by management, but if it does slightly fall short, it certainly would come in the following first fiscal quarter of 2020.

Conclusion

Aurora Cannabis is undervalued in my opinion, primarily because the market has looked for it to operate in conventional, traditional fashion, but instead has chosen to compete on its own terms.

Source: https://finance.yahoo.com/news/aurora-cannabis-acb-stock-substantial-144245681.html

VANCOUVER , June 10, 2019 /CNW/ – Saskatoon residents can now order cannabis to their doorstep within two hours of online purchase, thanks to a new partnership between Vancouver -based cannabis brand Kiaro and Pineapple Express Delivery.

The distribution agreement enables Kiaro to provide expedited delivery of cannabis products throughout Saskatoon within two hours or less, supporting the brand’s ongoing commitment to provide a customer forward service that surpasses expectations and adds significant value beyond the transaction. The agreement also improves accessibility of legal cannabis products, thereby supporting the disruption of the unregulated market, as outlined in the Cannabis Act. 

Kiaro offers a diverse product portfolio appealing to the cannabis curious as well as seasoned connoisseurs. Items featured in the e-commerce shop include dried flower, pre-rolls, tinctures, capsules and accessories; and offerings will expand as new product categories, such as edibles and topicals, enter the regulated market in October. To enjoy expedited cannabis delivery, customers simply need to purchase their desired products on kiaro.com, then select “Pineapple Express” as the delivery option.

Pineapple Express Delivery boasts more than a decade of experience in on-demand shipment across multiple industries, and recently expanded into the recreational cannabis space. The company’s comprehensive service includes live GPS tracking, so customers know exactly when to expect their goods. Deliveries are executed under strict security and shipment protocols, and comply with provincial and federal industry regulations.

“Providing our customers with the option of expedited delivery marks a significant milestone in Kiaro’s history, one that we hope will contribute to the normalization of cannabis consumption,” said Daniel Petrov , CEO, Kiaro. “As we continue to expand our footprint across Canada , our goal is to enhance life enjoyment for a greater number of clients, and expedited delivery of our products is an important step to achieving that goal.”

“We are delighted to partner with Kiaro and support the company’s ongoing mission to legitimize the cannabis industry through convenient and inviting retail experiences,” said Randy Rolph , CEO, Pineapple Express. “Kiaro has earned a well-deserved reputation for providing exceptional customer service, and we hope to exceed expectations even further by enabling expedited delivery of their cannabis products.”

Kiaro currently owns two brick-and-mortar locations in Saskatchewan ( Saskatoon and La Ronge ), both of which are supported by the company’s e-commerce platform. For more information, and to experience the partnership with Pineapple Express Delivery, visit kiaro.com.

About Kiaro:
Kiaro is a Vancouver -based cannabis brand that carries a variety of curated products appealing to individuals who wish to enhance their life enjoyment through cannabis. The company plans to open a number of fully compliant retail stores across Canada and, through its stores and e-commerce platform, offer a customized omni-channel cannabis experience that is inviting, convenient and appealing, allowing consumers to choose safe and reputable products.  Kiaro’s name derives from the Italian word chiaroscuro, meaning “to emerge from the darkness into light” – a nod to the new era of cannabis legalization.

Langley, British Columbia – (May 14th, 2019) – Langley BC Cannabis Ltd. (the “Company”) a prospective licensed cannabis cultivator under the Cannabis Act, is seeking to raise $5 Million in gross proceeds through the sale of 10,000,000 shares at $0.50 per share. This first round of financing is open to the Canadian market and will go to fund the facility purchase and construction retrofitting of their phase 1 facility, located in Langley British Columbia. Negotiations for the purchase of the Phase 1 facility are currently in their final phase.

Co-Founder and CEO of the company, Dion Tarbaj stated “We are very pleased to be opening up this first round of financing to investors. With this funding in place, we will be able to begin construction on our phase 1 facility and move forward with our goal to receive a cultivation license from Health Canada”

This Phase 1 facility will be one of three initial planned expansions of Langley BC Cannabis LTD. facilities. With Phase 2 already in the planning stages, The Company aims to have both facilities licensed and operational by the end of 2021. Phase 1 is estimated to produce an estimated 4,500kg of dried cannabis in its first year with further expansion of that capacity in following fiscal years.

About the Company:

Langley BC Cannabis is an early stage cannabis cultivator applicant under Health Canada’s Cannabis Act based in Langley BC, Canada. They have submitted their application to Health Canada and await the approval of Health Canada to begin cultivation of their first crop. The Company plans to produce high quality medical grade cannabis that will be affordable and accessible to all Canadians.

Media Contact:

Dion Tarbaj, Chief Executive Officer

Langley BC Cannabis Ltd.
2nd Floor, 8661 201 Street
Langley, BC, V2Y 0G9
Email:   dion@langleymj.com
Website: https://langleymj.com
Phone: +1-866-274-9286